PL107142B1 - Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu - Google Patents

Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu Download PDF

Info

Publication number
PL107142B1
PL107142B1 PL1977202753A PL20275377A PL107142B1 PL 107142 B1 PL107142 B1 PL 107142B1 PL 1977202753 A PL1977202753 A PL 1977202753A PL 20275377 A PL20275377 A PL 20275377A PL 107142 B1 PL107142 B1 PL 107142B1
Authority
PL
Poland
Prior art keywords
mixture
formula
compounds
symbols
compound
Prior art date
Application number
PL1977202753A
Other languages
English (en)
Polish (pl)
Other versions
PL202753A1 (pl
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51426/76A external-priority patent/GB1585965A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of PL202753A1 publication Critical patent/PL202753A1/xx
Publication of PL107142B1 publication Critical patent/PL107142B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1977202753A 1976-12-09 1977-12-08 Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu PL107142B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB51426/76A GB1585965A (en) 1976-12-09 1976-12-09 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
GB3334177 1977-08-09

Publications (2)

Publication Number Publication Date
PL202753A1 PL202753A1 (pl) 1978-10-09
PL107142B1 true PL107142B1 (pl) 1980-01-31

Family

ID=26261828

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977202753A PL107142B1 (pl) 1976-12-09 1977-12-08 Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu

Country Status (23)

Country Link
US (1) US4167569A (enExample)
JP (1) JPS5390296A (enExample)
AT (1) AT359068B (enExample)
AU (1) AU514427B2 (enExample)
CA (1) CA1086727A (enExample)
CH (1) CH633291A5 (enExample)
CS (1) CS199696B2 (enExample)
DD (1) DD133330A5 (enExample)
DE (1) DE2754930A1 (enExample)
ES (1) ES464862A1 (enExample)
FI (1) FI63577C (enExample)
FR (1) FR2373543A1 (enExample)
GR (1) GR65298B (enExample)
HU (1) HU176540B (enExample)
IE (1) IE45924B1 (enExample)
IL (1) IL53507A (enExample)
IT (1) IT1143729B (enExample)
NL (1) NL7713658A (enExample)
NO (1) NO774216L (enExample)
NZ (1) NZ185823A (enExample)
PL (1) PL107142B1 (enExample)
SE (1) SE435385B (enExample)
SU (1) SU843751A3 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
CA1157858A (en) 1979-12-03 1983-11-29 Ikuo Ueda Quinazoline derivatives
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
RU2394824C1 (ru) * 2008-12-25 2010-07-20 Государственное научное учреждение Северо-Кавказский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук ПРОИЗВОДНЫЕ ПИРИДО [1,2-a]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ АНТИБАКТЕРИАЛЬНЫМ ДЕЙСТВИЕМ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
AU2013283318B2 (en) 2012-06-27 2017-11-23 4Sc Ag Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides

Also Published As

Publication number Publication date
SU843751A3 (ru) 1981-06-30
DE2754930A1 (de) 1978-06-15
GR65298B (en) 1980-08-01
FI63577C (fi) 1983-07-11
CS199696B2 (en) 1980-07-31
CA1086727A (en) 1980-09-30
NO774216L (no) 1978-06-12
ES464862A1 (es) 1979-01-01
US4167569A (en) 1979-09-11
SE435385B (sv) 1984-09-24
FI773724A7 (fi) 1978-06-10
HU176540B (en) 1981-03-28
IE45924L (en) 1978-06-09
ATA883677A (de) 1980-03-15
AU514427B2 (en) 1981-02-12
IE45924B1 (en) 1982-12-29
AT359068B (de) 1980-10-27
JPS5390296A (en) 1978-08-08
NZ185823A (en) 1980-08-26
FR2373543A1 (fr) 1978-07-07
CH633291A5 (de) 1982-11-30
PL202753A1 (pl) 1978-10-09
FI63577B (fi) 1983-03-31
FR2373543B1 (enExample) 1980-05-16
IT1143729B (it) 1986-10-22
NL7713658A (nl) 1978-06-13
SE7713958L (sv) 1978-06-10
IL53507A0 (en) 1978-03-10
AU3112177A (en) 1979-06-07
DD133330A5 (de) 1978-12-27
IL53507A (en) 1981-07-31

Similar Documents

Publication Publication Date Title
CS265248B2 (en) Process for preparing analogs of rebeccamycine
EP0188094A2 (en) Quinazoline derivatives and antihypertensive preparations containing same as effective components
PL136217B1 (en) Method of obtaining novel derivatives of 4-amino-6,7-dimetoxy-2-piprazinoquinazoline
US4284773A (en) 1,2,3,5-Tetrahydroimidazothienopyrimidin-2-ones
DE69533043T2 (de) Acrylamid-derivate und verfahren zu deren herstellung
CA1330079C (en) Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
Blanz Jr et al. A Systematic Investigation of Thioxanthen-9-ones and Analogs as Potential Antitumor Agents1, 2
EP0055444B1 (de) Trisubstituierte Pyrimido(5,4-d)pyrimidine, ihre Herstellung und diese enthaltende Arzneimittel
PL160044B1 (pl) Sposób wytwarzania pochodnych imidazopirydazyny PL PL PL
IE66181B1 (en) New imidazo [1,2-c] quinazoline derivatives process for preparing these and pharmaceutical compositions containing them
PL107142B1 (pl) Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu
Bliss et al. Structural studies on bio-active compounds. Part 5. Synthesis and properties of 2, 4-diaminopyrimidine dihydrofolate reductase inhibitors bearing lipophilic azido groups
CH661273A5 (de) Mitomycinanaloge, welche eine disulfidgruppe enthalten.
US3637699A (en) Dialkyl-substituted-4-(hydroxyalkyl-bearing)aminoquinazolines nitrates
Wahe et al. Heterocycles of biological importance. Part 6. The formation of novel biologically active pyrimido [1, 2-a] benzimid-azoles from electron deficient alkynes and 2-aminobenzimidazoles
Trybulski et al. 2-Benzazepines. 5. Synthesis of pyrimido [5, 4-d][2] benzazepines and their evaluation as anxiolytic agents
Pomarnacka et al. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)-1, 3, 5-triazine derivatives
US4772628A (en) Organogermanium compound and antitumor agent composed mainly of this compound
US4372956A (en) 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them
US4452982A (en) Process for the preparation of nitrogen-bridgehead condensed pyrimidine compounds, and pharmaceutical compositions containing them
US5374739A (en) Mitomycin analogs
GB1585965A (en) 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
Gal Pteridine Studies. I. Mercaptopteridines
PT97147A (pt) Processo para a preparacao de derivados da 4h-pirrolo{1,2-a}tieno{2,3-f}{1,4}diazepina e de composicoes farmaceuticas que os contem
유희원 et al. The Reaction of 6, 7-Dichloro-5, 8-quinoxalinedione with Aromatic and Aliphatic Dinucleophiles and Molecular Modeling Study of Their Intercalation Complexes